| Makale Türü |
|
||
| Dergi Adı | Turkish Neurosurgery (Q4) | ||
| Dergi ISSN | 1019-5149 Dergi Bilgileri (2020) | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 05-2020 |
| Cilt / Sayı / Sayfa | 30 / 3 / 350–353 | DOI | 10.5137/1019-5149.JTN.21557-17.4 |
| Makale Linki | http://www.turkishneurosurgery.org.tr/summary_en_doi.php3?doi=10.5137/1019-5149.JTN.21557-17.4 | ||
| UAK Araştırma Alanları |
Tıbbi Biyoloji
|
||
| Özet |
| AIM: To investigate the expression of the DR4, DR5, OPG, DcR1, and DcR2 in rat brain tissue.MATERIAL and METHODS: Thirty rats were used in this study. The rats were divided into three groups as the control group (n=10),tumor group (n=10), and zincoxide (ZnO) nanoparticles (NP) treatment group (n=10). The reverse transcription polymerase chainreaction (RT-PCR) and Western Blotting methods were used to measure the expression of DR4, DR5, OPG, DcR1, DcR2 and β-actinin the brain tissues of all the three groups.RESULTS: Expression of DR4, DR5, OPG, DcR1, and DcR2 genes were decreased in the tumor group. Overexpression of DR4,DR5, OPG, DcR1, and DcR2 was observed in brain tissues of the ZnO-NP group.CONCLUSION: Increased expression of the DR4, DR5, OPG, DcR1, and DcR2 genes may play an important role in ZnO-NPtreatment of brain tumors. |
| Anahtar Kelimeler |
| Dergi Adı | Turkish Neurosurgery |
| Kısa Adı | TURK NEUROSURG |
| Yayıncı | TURKISH NEUROSURGICAL SOC |
| Açık Erişim | Hayır |
| ISSN | 1019-5149 |
| E-ISSN | 1019-5149 |
| Wos Quartile | Q4 |
| Scopus Quartile | Q3 |
| Tarandığı Indeksler | SCIE , Scopus |
| WoS Kategoriler | CLINICAL NEUROLOGY | SURGERY |
| Scopus Kategoriler | NEUROLOGY (CLINICAL) | SURGERY |